MeSH term
Frequency | Condition_Probility | Animals | 16 | 0.0 |
*Colorectal Neoplasms/diagnosis/metabolism/pathology/therapy | 2 | 3.0 |
Humans | 26 | 0.0 |
*Cell Cycle Proteins | 10 | 0.0 |
*DNA-Binding Proteins | 13 | 0.0 |
Mice | 10 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 18 | 0.0 |
3T3 Cells | 3 | 0.0 |
Apoptosis | 2 | 0.0 |
Binding Sites | 3 | 0.0 |
Cell Line | 3 | 0.0 |
*Trans-Activation (Genetics) | 2 | 0.0 |
Transcription Factors/*physiology | 2 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Cell Division | 5 | 0.0 |
Male | 9 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 15 | 0.0 |
Transfection | 3 | 0.0 |
Cell Aging/*physiology | 2 | 3.0 |
Cells, Cultured | 7 | 0.0 |
Signal Transduction/physiology | 3 | 0.0 |
Transcription Factors/*genetics | 2 | 0.0 |
Adult | 2 | 0.0 |
Aged | 2 | 0.0 |
Cell Cycle Proteins/*metabolism | 4 | 1.0 |
Comparative Study | 2 | 0.0 |
Female | 4 | 0.0 |
Middle Aged | 2 | 0.0 |
*Proto-Oncogene Proteins c-bcl-2 | 2 | 0.0 |
Cell Cycle/drug effects | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Blotting, Northern | 4 | 0.0 |
*Carrier Proteins | 6 | 1.0 |
Cell Cycle/genetics | 3 | 2.0 |
DNA Replication | 3 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Tumor Cells, Cultured | 9 | 0.0 |
Cell Cycle/*physiology | 2 | 0.0 |
In Situ Nick-End Labeling | 2 | 0.0 |
Mice, Transgenic | 3 | 0.0 |
Protein p53/metabolism | 2 | 0.0 |
Transcription Factors/*metabolism | 4 | 0.0 |
Base Sequence | 3 | 0.0 |
Gene Expression Regulation | 5 | 0.0 |
Molecular Sequence Data | 3 | 0.0 |
Proto-Oncogene Proteins c-myc/metabolism | 2 | 2.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Phosphorylation | 3 | 0.0 |
*Proto-Oncogene Proteins | 2 | 0.0 |
Retinoblastoma Protein/metabolism | 2 | 0.0 |
S Phase/physiology | 3 | 3.0 |
Transcription Factors/genetics/*metabolism | 3 | 0.0 |
G1 Phase | 2 | 0.0 |
Gene Amplification | 2 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
Chromosomes, Human, Pair 1/*genetics | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Neuroblastoma/*genetics | 2 | 2.0 |
Cell Cycle | 3 | 0.0 |
Mutation | 2 | 0.0 |
Rats | 2 | 0.0 |
Down-Regulation/drug effects | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
Promoter Regions (Genetics) | 5 | 0.0 |
Apoptosis/physiology | 2 | 0.0 |
Cell Cycle Proteins/genetics | 2 | 2.0 |
Apoptosis/*physiology | 2 | 0.0 |
Nuclear Proteins/*metabolism | 2 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Chromatin/metabolism | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Precipitin Tests | 2 | 0.0 |
